Home > Insider Trading > Filing (0001415889-23-014511)

Filing Details

Accession Number:: 0001415889-23-014511
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-10-24 21:45:16
Reporting Period:: 2023-10-20

Accepted Time:: 2023-10-24 21:45:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1697362	Burkes Michael Brophy	C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-10-20	1,522	$0.00	66,355	No	4	M	Direct
Common Stock	Acquisiton	2023-10-21	1,145	$0.00	67,500	No	4	M	Direct
Common Stock	Acquisiton	2023-10-22	1,250	$0.00	68,750	No	4	M	Direct
Common Stock	Disposition	2023-10-23	1,565	$40.39	67,185	No	4	S	Direct
Common Stock	Disposition	2023-10-23	2,172	$40.37	65,013	No	4	S	Direct
Common Stock	Disposition	2023-10-23	203	$40.90	64,810	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2023-10-20	1,522	$0.00	1,522	$0.00
Common Stock	Restricted Stock Unit	Disposition	2023-10-21	1,145	$0.00	1,145	$0.00
Common Stock	Restricted Stock Unit	Disposition	2023-10-22	1,250	$0.00	1,250	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,696	No	4	M	Direct
5,725	No	4	M	Direct
10,000	No	4	M	Direct

Footnotes

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2022. The Reporting Person is subject to a Lock-up Letter Agreement that expires on November 5, 2023. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.80 to $40.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.81 to $40.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These reported shares are subject to restrictions in the Lock-Up Letter Agreement.
The RSUs vest over four years. 25% of the RSUs vest on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.
The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.
The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.